Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -46.57x is in line with its 5-year average of -50.37x, near the high end of its 5-year range (-412.55x–-2.25x).
As of the fiscal period ended Sunday, June 30, 2024. 27.16% below its 12-month average of -36.62x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2024 (2024-06-30): -46.57x.
INTEREST COVERAGE RATIO
-46.57x
INTEREST COVERAGE RATIO AVG TTM
-36.62x
INTEREST COVERAGE RATIO AVG 3Y
-21.32x
INTEREST COVERAGE RATIO AVG 5Y
-50.37x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-27.16%
CURRENT VS 3Y AVG
-118.46%
CURRENT VS 5Y AVG
+7.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.22x
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
-648.14%
vs the sector median at left
Delcath Systems, Inc.
Market Cap
$535.07M
Interest Coverage Ratio
-46.57x
TTM Avg
-36.62x
3Y Avg
-21.32x
5Y Avg
-50.37x
Market Cap
$531.78M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$535.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$533.65M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$536.14M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$531.28M
Interest Coverage Ratio
-41251.75x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$530.31M
Interest Coverage Ratio
-2.35x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$523.67M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$518.71M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | $535.07M | -46.57x | -36.62x | -21.32x | -50.37x |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $531.78M | N/A | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $535.61M | N/A | N/A | N/A | N/A |
| Shattuck Labs, Inc. (STTK)vs › | $533.65M | N/A | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $536.14M | N/A | N/A | N/A | N/A |
| ProKidney Corp. (PROK)vs › | $531.28M | -41251.75x | N/A | N/A | N/A |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $530.31M | -2.35x | N/A | N/A | N/A |
| Monopar Therapeutics Inc. (MNPR)vs › | $523.67M | N/A | N/A | N/A | N/A |
| Immix Biopharma, Inc. (IMMX)vs › | $518.71M | N/A | N/A | N/A | N/A |
| Altimmune, Inc. (ALT)vs › | $514.38M | -57.76x | N/A | N/A | N/A |
Interest Coverage
-46.6x
Debt/Equity
0.02
Current Ratio
9.83
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-06-30 | -46.57x |
| 2024-03-31 | -51.65x |
| 2023-09-30 | -26.72x |
| 2023-06-30 | -21.56x |
| 2023-03-31 | -12.10x |
| 2022-12-31 | -14.77x |
| 2022-09-30 | -11.20x |
| 2022-06-30 | -14.26x |
| 2022-03-31 | -12.93x |
| 2021-12-31 | -6.80x |
| 2021-09-30 | -15.94x |
| 2021-06-30 | -161.28x |
| 2021-03-31 | -164.07x |
| 2020-12-31 | -332.38x |
| 2020-09-30 | -113.18x |
| 2020-06-30 | -82.10x |
| 2020-03-31 | -140.94x |
| 2019-12-31 | -412.55x |
| 2019-09-30 | -8.30x |
| 2019-06-30 | -2.25x |
| 2019-03-31 | -2.55x |
| 2018-12-31 | -1.69x |
| 2018-09-30 | -1.84x |
| 2018-06-30 | -24.56x |
| 2018-03-31 | -3751.50x |
| 2017-12-31 | -3.42x |
| 2017-09-30 | -0.92x |
| 2017-06-30 | -0.67x |
| 2017-03-31 | -0.50x |
| 2016-09-30 | -0.95x |
| 2016-06-30 | -2.40x |
| 2015-09-30 | -260.71x |
